Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 077603
Company: MYLAN
Company: MYLAN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 4MG BASE | TABLET;ORAL | Discontinued | None | No | No |
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 8MG BASE | TABLET;ORAL | Discontinued | None | No | No |
| GALANTAMINE HYDROBROMIDE | GALANTAMINE HYDROBROMIDE | EQ 12MG BASE | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 08/28/2008 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/077603s000ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/14/2017 | SUPPL-2 | Labeling-Package Insert |
Label is not available on this site. |